Funded Tech Companies

Glyscend Therapeutics

Headquartered in Baltimore, Glyscend Therapeutics raised its funding from Brandon Capital Partners, Sante Ventures and private investors.

Company Overview

Company Name
Glyscend Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
1812 Ashland Ave. 110
Baltimore, MD 21205
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Glyscend, Inc. is a venture-backed biopharmaceutical company developing novel orally-delivered compounds that work on targets inside the GI tract to treat a variety of metabolic disorders, including T2D.
Profile
Glyscend Therapeutics LinkedIn Company Profile
Social Media
Glyscend Therapeutics Company Twitter Account
Company News
Glyscend Therapeutics News
Facebook
Glyscend Therapeutics on Facebook
YouTube
Glyscend Therapeutics on YouTube
Last Transaction
6/12/2020

Financing History

Date
Type
Amount
Venture Equity
$20,500,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Ashish Nimgaonkar
  Ashish Nimgaonkar LinkedIn Profile  Ashish Nimgaonkar Twitter Account  Ashish Nimgaonkar News  Ashish Nimgaonkar on Facebook
Chief Scientific Officer
Thomas Jozefiak
  Thomas Jozefiak LinkedIn Profile  Thomas Jozefiak Twitter Account  Thomas Jozefiak News  Thomas Jozefiak on Facebook
VP - Product Management
John Petersen
  John Petersen LinkedIn Profile  John Petersen Twitter Account  John Petersen News  John Petersen on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Glyphr | GlySens

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary